5152 related articles for article (PubMed ID: 6179045)
1. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. I. Activity concentrations in transplantable tumours and organs-tissues of mice.
Rembelska MJ; Liniecki J
Nuklearmedizin; 1982 Apr; 21(2):62-7. PubMed ID: 6179045
[TBL] [Abstract][Full Text] [Related]
2. Uptake of labelled tallysomycin by solid Ehrlich ascites tumors in mice.
Liniecki J; Rembelska M; Koniarek B
Nuklearmedizin; 1983 Jun; 22(3):159-61. PubMed ID: 6194513
[TBL] [Abstract][Full Text] [Related]
3. Uptake of main fractions of labelled bleomycin by solid Ehrlich ascites tumours in mice.
Rembelska M; Liniecki J; Koniarek B; Krawczyk Z
Nuklearmedizin; 1984 Jun; 23(3):127-9. PubMed ID: 6207486
[TBL] [Abstract][Full Text] [Related]
4. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
Zimmermann M; Hale T
Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
[TBL] [Abstract][Full Text] [Related]
5. 111-In-bleomycin kinetics in mice bearing transplantable tumors of lung, skin, and bone.
Robbins PJ; Silberstein EB; Fortman DL
J Nucl Med; 1974 Apr; 15(4):273-8. PubMed ID: 4131859
[No Abstract] [Full Text] [Related]
6. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
[TBL] [Abstract][Full Text] [Related]
7. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. II. Scintigraphic diagnosis of malignant neoplasms.
Liniecki J; Brykalski D; Pertyński T; Rembelska M; Durski K; Fajndt S
Nuklearmedizin; 1982 Apr; 21(2):68-71. PubMed ID: 6179046
[TBL] [Abstract][Full Text] [Related]
8. Comparison of uptake of 67Ga-citrate and 57Co-bleomycin in tumor using a semiconductor detector.
Higashi T; Kanno M; Tomura K
J Nucl Med; 1974 Dec; 15(12):1167-70. PubMed ID: 4139249
[No Abstract] [Full Text] [Related]
9. [Characteristics of 57Co-bleomycetin accumulation in the primary tumor and in its metastases to the lungs in mice with Lewis carcinoma].
Vatin OE; Petriev VM; Prusova RM
Antibiotiki; 1983 Sep; 28(9):686-9. PubMed ID: 6195962
[TBL] [Abstract][Full Text] [Related]
10. Intracellular distribution of 57Co-bleomycin.
Konings AW; Rasker JJ; Posthuma GA
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):497-512. PubMed ID: 76527
[TBL] [Abstract][Full Text] [Related]
11. [Labeling reactions of L-lysine and poly-L-lysine with 57Co and their distribution in normal and Ehrlich ascites tumor-bearing mice (author's transl)].
Motohashi N; Terao M; Mori I
Radioisotopes; 1981 Feb; 30(2):80-5. PubMed ID: 6794106
[TBL] [Abstract][Full Text] [Related]
12. Chemical and biologic properties of isolated radiolabeled bleomycin preparations.
Eckelman WC; Rzeszotarski WJ; Siegel BA; Kubota H; Chelliah M; Stevenson J; Rebra RC
J Nucl Med; 1975 Nov; 16(11):1033-7. PubMed ID: 52699
[TBL] [Abstract][Full Text] [Related]
13. [Distribution of various 57Co-labelled zhengguangmycin preparations in Ehrlich carcinoma bearing mice in relation with their antitumor activity and toxicity (author's transl)].
Xue SB; Liu HT; Zhang HQ; Li DD; Lin HY
Yao Xue Xue Bao; 1980 Jan; 15(1):1-6. PubMed ID: 6161520
[No Abstract] [Full Text] [Related]
14. DNA interaction with 57Co-bleomycin.
Kakinuma J; Orii H
Nuklearmedizin; 1982 Dec; 21(6):232-5. PubMed ID: 6188112
[TBL] [Abstract][Full Text] [Related]
15. [Influence of radiotherapy upon tumor accumulation and organ distribution of 57Co-bleomycin in mice with chemically induced squamous cell carcinoma (author's transl)].
Pertynski T; Ketkar MB; Mariss P; Reznik G; Hassenstein E; Nüsslin F; Dieffenbach G; Haindl H
Strahlentherapie; 1979 Nov; 155(11):770-3. PubMed ID: 92831
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on the uptake and organ distribution of 57Co-bleomycin and 57Co-bleomycin-A2 in mice with squamous cell tumors of the skin and vagina].
Pertynski T; Ketkar MB; Mariss P; Reznik G; Talas A; Dieffenbach G
Nuklearmedizin; 1979; 18(6):300-3. PubMed ID: 94162
[No Abstract] [Full Text] [Related]
17. [Positive tumor scintigraphy. I. Pharmacokinetics of 111In and 57Co bleomycin].
Blottner A; Deckart H; Weiland J
Radiobiol Radiother (Berl); 1978 Jun; 19(3):365-77. PubMed ID: 82976
[No Abstract] [Full Text] [Related]
18. [Energy metabolism of Ehrlich tumor and lymphoma Nk-Ly cells in the process of tumor growth].
Kaz'min SD; Mel'nikova NN
Vopr Onkol; 1972; 18(3):66-70. PubMed ID: 5017841
[No Abstract] [Full Text] [Related]
19. [57Co-bleomycetin pharmacokinetics in the body of mice with LIO-1 lymphosarcoma].
Petriev VM; Vatin AE; Prusova RM; Filatov PP; Khachirov DG
Antibiotiki; 1982 Aug; 27(8):623-6. PubMed ID: 6181732
[TBL] [Abstract][Full Text] [Related]
20. Distribution of labeled bleomycin in normal and tumor-bearing mice.
Grove RB; Eckelman WC; Reba RC
J Nucl Med; 1973 Dec; 14(12):917-9. PubMed ID: 4127738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
